Details for New Drug Application (NDA): 017442

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 017442 describes MINIPRESS, which is a drug marketed by Pfizer and is included in two NDAs. It is available from four suppliers. Additional details are available on the MINIPRESS profile page.

The generic ingredient in MINIPRESS is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.

Summary for 017442

Tradename:	MINIPRESS
Applicant:	Pfizer
Ingredient:	prazosin hydrochloride
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 017442

Mechanism of Action	Adrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for 017442

Adrenergic alpha-1 Receptor Antagonists
Antihypertensive Agents

Suppliers and Packaging for NDA: 017442

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442	NDA	Pfizer Laboratories Div Pfizer Inc	0069-4310	0069-4310-71	250 CAPSULE in 1 BOTTLE (0069-4310-71)
MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442	NDA	Pfizer Laboratories Div Pfizer Inc	0069-4370	0069-4370-71	250 CAPSULE in 1 BOTTLE (0069-4370-71)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 5MG BASE
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 1MG BASE
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 2MG BASE
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Expired US Patents for NDA 017442

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-003	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-002	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-003	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.